Nocion Therapeutics
Cambridge
About Nocion Therapeutics
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment of serious conditions including cough, itch, pain and inflammation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $134.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2026)
- Website: nociontx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/nocion-therapeutics-24765 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.